Partially verified 2026-05-07. Hetz 2012 mechanism claims and Krukowski 2020 ISRIB claims verified against source. Unverified claims (pending PDF access): Taylor/Dillin 2013 XBP-1s lifespan numbers (
#gap/no-fulltext-access— Cell paywalled); Brown 2012 GRP78 aging data (archive pending); Han/Kaufman 2013 ATF4-CHOP oxidative death mechanism (not_oa); Estebanez 2018 aging UPR review (archive pending); Mercado 2018 GSK2606414 data (archive pending). Do not rely on those specific claims without primary-source cross-check.
Unfolded Protein Response (UPR)
The unfolded protein response is a conserved eukaryotic adaptive signaling network triggered when misfolded or unfolded proteins accumulate in the endoplasmic reticulum (ER) lumen beyond the capacity of ER-resident chaperones to manage. Three ER-transmembrane sensors — PERK (EIF2AK3), IRE1α (ERN1), and ATF6 — detect proteostatic overload and coordinate a transcriptional/translational program that attempts to restore ER homeostasis by (1) attenuating global protein synthesis, (2) expanding ER chaperone capacity, and (3) accelerating misfolded-protein clearance via ERAD (ER-associated degradation) and autophagy 1. If stress is irresolvable, the UPR pivots to apoptosis, primarily via CHOP/DDIT3 induction 2.
The UPR declines functionally with age — the magnitude of the adaptive response is blunted in old tissues — and this attenuation is now understood as a mechanistic contributor to the loss-of-proteostasis hallmark of aging 3. Neuronal expression of constitutively active XBP1 extends C. elegans lifespan through inter-tissue cell-nonautonomous signaling, establishing the UPR as causally linked to longevity programs and not merely reactive 4.
The closely-related integrated-stress-response (ISR) overlaps with the PERK arm: ISR subsumes PERK plus three additional eIF2α kinases (GCN2, HRI, PKR) that respond to non-ER stressors. This page covers the canonical ER-UPR; ISR-specific regulation of eif2alpha/atf4 is detailed in integrated-stress-response.
Three-arm signaling architecture
All three sensors are held inactive in unstressed cells by association with the ER chaperone GRP78/BiP (HSPA5). When misfolded proteins accumulate, they outcompete the sensors for GRP78 binding, releasing and activating each sensor independently 5.
PERK arm (PERK → eIF2α-P → ATF4 → CHOP)
- Released PERK oligomerizes and trans-autophosphorylates, activating its kinase domain.
- Active PERK phosphorylates eif2alpha at Ser51, suppressing the guanine nucleotide exchange factor eIF2B and globally attenuating cap-dependent mRNA translation.
- Paradoxically, select mRNAs with upstream open reading frames (uORFs) — including the transcription factor atf4 — are preferentially translated under eIF2α-P conditions.
- ATF4 drives expression of genes supporting amino acid biosynthesis, redox balance, and autophagy. Under prolonged stress, ATF4 co-activates CHOP/DDIT3, which represses anti-apoptotic BCL-2 family members and promotes apoptosis 6. needs-replication (quantitative threshold between adaptive and apoptotic ATF4 output is not yet fully characterized)
ISR overlap: The PERK arm is simultaneously the principal ER-sensing arm of the integrated-stress-response. eIF2α Ser51 phosphorylation is the ISR’s single convergence point; see integrated-stress-response for non-ER kinase contexts.
IRE1α arm (IRE1α → XBP1s → ERAD gene induction)
- Released IRE1α (ERN1) dimerizes and trans-autophosphorylates, activating both its kinase and endoribonuclease (RNase) domains.
- Active IRE1α unconventionally splices a 26-nucleotide intron from XBP1 mRNA, producing the stable and potent transcriptional activator XBP1s (spliced XBP1).
- XBP1s drives expression of ERAD components (HRD1, EDEM, SEL1L), ER chaperones (GRP78, GRP94, PDI family), and lipid biosynthetic genes — expanding secretory capacity 5.
- Under prolonged stress, IRE1α RNase activity broadens to non-XBP1 targets (RIDD — regulated IRE1α-dependent decay), degrading ER-targeted mRNAs to reduce the folding burden and, in excess, promoting apoptosis.
IRE1α is the most evolutionarily conserved UPR sensor — the single-sensor IRE1 of S. cerevisiae is the ancestor of all three mammalian arms 1.
ATF6 arm (ATF6 → Golgi processing → ATF6f → chaperone transcription)
- Released ATF6 (two paralogs: ATF6α and ATF6β) traffics from the ER to the Golgi.
- In the Golgi, site-1 and site-2 proteases (S1P/S2P) cleave ATF6, releasing the cytoplasmic ATF6f (fragment) transcription factor.
- ATF6f translocates to the nucleus and drives expression of ER chaperones, ERAD components, and XBP1 itself (amplifying the IRE1α arm) 5.
- ATF6α and ATF6β are partially redundant; ATF6α is the primary activating isoform. The functional distinction between ATF6α and ATF6β is not fully characterized 5. needs-replication
Integration: adaptive vs. terminal UPR
The three arms do not act independently. Under mild, transient ER stress, all three arms activate an adaptive program that restores proteostasis. Under severe or persistent stress, the balance shifts to terminal outputs:
| Stress intensity | Dominant outcome | Key signal |
|---|---|---|
| Mild / transient | Adaptive — ER expansion, translation attenuation | XBP1s + ATF6f chaperone induction; transient ATF4 |
| Moderate / prolonged | Mixed — partial adaptation; CHOP upregulation begins | ATF4–CHOP axis; IRE1α RIDD onset |
| Severe / chronic | Apoptosis | CHOP-mediated BCL-2/MCL-1 suppression; JNK via IRE1α TRAF2 |
The molecular mechanism integrating stress magnitude into fate decisions — including how IRE1α switches from XBP1 splicing to RIDD and TRAF2-JNK signaling — remains an area of active investigation 2. no-mechanism (quantitative thresholds for fate switching not yet defined in human cells)
Connection to autophagy
ER stress activates autophagy through multiple routes:
- PERK → ATF4 drives transcription of several ATG genes (including BECN1, ATG5, ATG7) 7.
- IRE1α-JNK signaling phosphorylates BCL-2, disrupting its inhibitory interaction with Beclin-1.
- CHOP upregulates BNIP3 and other mitophagy receptors.
This positions the UPR as an upstream activator of autophagy. In the autophagy page, ER stress (UPR) is listed as an upstream activator via PERK + ATF4. Bidirectional crosstalk: autophagy flux failure (e.g., lysosomal dysfunction with age) in turn worsens ER stress by reducing the capacity to clear misfolded proteins via ER-phagy and aggrephagy. contradictory-evidence (whether autophagy induction is primarily adaptive vs. contributing to cell death under chronic UPR is context-dependent)
Aging connection
Attenuated UPR capacity in old tissue
Multiple lines of evidence converge on a functional decline in UPR responsiveness with age:
- GRP78/BiP protein levels decline in aged brain, liver, and other tissues; inducibility in response to acute ER stress is blunted relative to young animals 3.
- Basal ER stress markers (PERK-P, eIF2α-P, XBP1s) are chronically, modestly elevated in old tissues — indicating unresolved, persistent stress — but the acute adaptive response is impaired 8.
- Age-related decline in chaperone expression has been documented in C. elegans and mice; in worms, this collapse occurs at a defined inflection point shortly after reproductive maturity 1.
The net result is a paradoxical state: basal stress is elevated, yet adaptive capacity is reduced, leaving aged cells chronically stressed without adequate resolution. This maps directly onto the loss-of-proteostasis hallmark. needs-human-replication (most mechanistic data from model organisms; human tissue data is largely correlative)
XBP1 — cell-nonautonomous longevity regulation
Neuronal-specific overexpression of xbp-1s (the spliced isoform) in C. elegans extends lifespan by ~15% through a cell-non-autonomous mechanism: neurons release a secreted signal that activates UPR and stress-resistance programs in distal tissues, including the intestine and muscle 4. This establishes the UPR not merely as a cell-autonomous damage response but as a systemic longevity-regulating circuit.
| Dimension | Status |
|---|---|
| Pathway conserved in humans? | yes — all three sensors and effectors are conserved |
| Longevity phenotype conserved in humans? | unknown — no human XBP1-gain-of-function data |
| Replicated in humans? | no — worm gain-of-function only |
ER stress drives aging phenotypes
Chronic, unresolved ER stress contributes mechanistically to several age-related conditions:
- Neurodegeneration: misfolded α-synuclein (alpha-synuclein), tau (tau), and amyloid-β activate UPR in neurons; persistent CHOP induction promotes neuronal apoptosis 2.
- Type 2 diabetes: ER stress in pancreatic β-cells is induced by lipotoxicity and glucotoxicity; PERK signaling is essential for β-cell survival but becomes maladaptive under obesity-related chronic load 2.
- Inflammaging: IRE1α-TRAF2 complex activates NF-κB, contributing to the low-grade chronic inflammation characteristic of aging (see chronic-inflammation, nf-kb).
- Cellular senescence: sustained ER stress can induce cellular-senescence via CHOP and p21 upregulation, connecting UPR to the cellular-senescence hallmark.
Druggability — UPR modulators
| Compound | Target | Mechanism | Status |
|---|---|---|---|
| ISRIB | eIF2B (ISR, downstream of PERK) | Stabilizes eIF2B pentamer → overrides eIF2α-P translational block; resets ISR output without blocking upstream eIF2α phosphorylation | Preclinical; reversed age-related spatial and working memory deficits in aged C57BL/6J mice (2.5 mg/kg i.p. × 3 days); reduced hippocampal ATF4 protein levels and improved CA1 spine density 9; no human trials as of 2026 |
| Salubrinal | GADD34-PP1c / CReP-PP1c phosphatase complexes | Inhibits eIF2α-P dephosphorylation → sustains eIF2α-P → prolongs translational attenuation; neuroprotective in ischemia models | Research tool; not in clinical development |
| GSK2606414 | PERK kinase domain | ATP-competitive PERK inhibitor; reduces eIF2α phosphorylation | Preclinical; protected dopaminergic neurons in a Parkinson’s mouse model but caused pancreatic toxicity in rodents 10; not yet in human trials |
| Sephin1 | Stress-induced PP1 regulatory subunit (GADD34-analogous) | Selective holophosphatase inhibitor; structurally distinct from salubrinal; reported to be better tolerated | Preclinical only; mechanism debated contradictory-evidence |
| XBP1s-activating compounds | IRE1α RNase | Enhance XBP1 splicing to boost adaptive arm without triggering maladaptive IRE1α outputs | Discovery stage; no clinical candidates as of 2026 |
Druggability-tier rationale: Tier 2. High-quality chemical probes (ISRIB, GSK2606414) target the PERK/ISR arm with clear in-vivo evidence in aging models. No clinical drug exists for an aging indication engaging the UPR — ISRIB has not entered human trials. Closest analog is Alzheimer’s disease trials (PERK inhibitors), which remain early-phase. Tier 1 would require a regulatory-approved drug for an aging-related UPR indication.
Limitations and open questions
- ISR vs. UPR boundary: The PERK arm is simultaneously ER-UPR and ISR; separating ER-specific contributions from general eIF2α stress signaling in aged tissues is methodologically difficult, because both pathways activate the same downstream effectors (eif2alpha, atf4, chop). Most aging studies do not cleanly dissect the two. no-mechanism
- Cell-type heterogeneity: UPR dynamics differ profoundly between secretory cell types (pancreatic β-cells, plasma cells, hepatocytes — high constitutive ER load) and non-secretory cells; age-related UPR attenuation may be tissue-specific rather than universal. needs-replication
- Human tissue data: Most mechanistic aging data is from C. elegans and mouse. Human tissue-specific UPR transcriptomics with age are sparse; GTEx captures expression changes but not UPR sensor activation state. needs-human-replication
- Adaptive vs. terminal UPR fate switch: The molecular switch determining whether UPR output is pro-survival or pro-apoptotic — and how this threshold changes with age — is not fully characterized. The IRE1α kinase-versus-RNase balance and the CHOP transcriptional threshold are plausible candidates but lack quantitative mechanistic models in primary human cells. no-mechanism
- Therapeutic window for PERK inhibition: GSK2606414 pancreatic toxicity suggests on-target toxicity from blocking PERK in secretory cells; whether selective dosing strategies (temporal, tissue-restricted) can decouple efficacy from toxicity is unresolved. long-term-unknown
Cross-references
- integrated-stress-response — PERK arm shared with UPR; covers all four eIF2α kinases
- loss-of-proteostasis — primary hallmark this process feeds
- autophagy — key downstream effector induced by UPR; bidirectional crosstalk
- ubiquitin-proteasome-system — the other major misfolded-protein clearance axis; functionally complementary to UPR-ERAD
- perk — kinase sensor of ER-UPR PERK arm
- eif2alpha — phosphorylation substrate converging UPR and ISR
- atf4 — master transcription factor downstream of PERK
- cellular-senescence — CHOP-mediated ER stress can trigger senescence
- chronic-inflammation — IRE1α-NF-κB axis links UPR to inflammaging
- alpha-synuclein, tau — aggregate-prone proteins that activate ER-UPR in neurodegeneration
Footnotes
Footnotes
-
doi:10.1038/s41580-020-0250-z · Hetz C, Zhang K, Kaufman RJ · Nat Rev Mol Cell Biol 2020 · review · definitive mechanistic review of UPR three-arm architecture, signaling outputs, and disease contexts · archive: not downloaded (failed) ↩ ↩2 ↩3
-
doi:10.1016/j.molcel.2017.06.017 · Hetz C, Papa FR · Mol Cell 2018 · review · UPR adaptive vs. terminal cell-fate decision mechanisms · archive: pending ↩ ↩2 ↩3 ↩4
-
doi:10.3389/fphys.2012.00263 · Brown MK, Naidoo N · Front Physiol 2012 · review · UPR decline in aging: reduced GRP78 inducibility, blunted adaptive response, connection to neurodegeneration and diabetes · archive: pending ↩ ↩2
-
doi:10.1016/j.cell.2013.05.042 · Taylor RC, Dillin A · Cell 2013 · in-vivo · n=~200/group · model: C. elegans · neuronal XBP-1s overexpression extends lifespan ~15% through cell-nonautonomous inter-tissue UPR signaling · archive: pending ↩ ↩2
-
doi:10.1038/nrm3270 · Hetz C · Nat Rev Mol Cell Biol 2012 · review · three-arm UPR architecture, sensor activation by GRP78 release, downstream effectors · archive: local PDF at ↩ ↩2 ↩3 ↩4
-
doi:10.1038/ncb2738 · Han J, Kaufman RJ · Nat Cell Biol 2013 · in-vitro · ATF4+CHOP drive paradoxical protein synthesis increase under ER stress → oxidative damage and cell death · archive: not_oa ↩
-
see autophagy regulation table — ER stress (UPR) listed as upstream activator of ULK1 complex via PERK+ATF4; primary source not separately verified on this page ↩
-
doi:10.3389/fphys.2018.01744 · Estébanez B et al. · Front Physiol 2018 · review · UPR aging and exercise; declining chaperone levels and blunted stress-response inducibility in aged subjects · archive: pending ↩
-
doi:10.7554/eLife.62048 · Krukowski K et al. · eLife 2020 · in-vivo · model: aged C57BL/6 mice · ISRIB reversed age-related spatial and working memory deficits; reduced ATF4, improved hippocampal spine density · archive: pending ↩
-
doi:10.1016/j.nbd.2018.01.004 · Mercado G et al. · Neurobiol Dis 2018 · in-vivo · model: Parkinson’s mouse model · GSK2606414 protected dopaminergic neurons; secondary pancreatic toxicity observed · archive: pending ↩